Atrial fibrillation|https://phgkb.cdc.gov/GAPPKB/phgHome.do|Atrial fibrillation

https://phgkb.cdc.gov/GAPPKB/phgHome.do

From Tier Table Database

CDC Office of Public Health Genomics (OPHG) conducts horizon scanning (a systematic research method to find and follow novel technologies appearing in the literature) to identify and track the progress of genomic tests as they move from research into clinical and public health practice. As an aid in organizing horizon scanning results, OPHG ranks genomic tests, and family health history applications, by levels of evidence. See detail.

---

Disease/Disorder	Test to be Assessed	Intended Use	Tier Classified	Detail
Atrial fibrillation	CYP2D6	Pharmacogenomic for propafenone	Tier 2
Venous thrombosis, pulmonary embolism, thromboembolic complications associated with atrial fibrillation and/or cardiac valve replacement, myocardial infarction	CYP2C9, VKORC1	Pharmacogenomic for warfarin dose	Tier 2

more